Technology Platform
Product Development Pipeline
Application Development
Partnering Opportunities

Regenerative Medicine Product Development - Locate Therapeutics

Locate Therapeutics (Locate) is a regenerative medicine product development company which has developed TAOS™ (Targeted Orchestrated Signalling matrix); a patented polymer technology with multiple medical applications.

The TAOS™ matrix system is a world-first in tissue repair. It is a unique regenerative medicine platform that provides an optimal structure to support tissue repair, and can precisely accommodate and promote the actions of locally-applied drugs, and emergent biological and cell-based therapies. TAOS’ injectable particulate formulation is thermally-triggered to solidify into a space-filling open porous depot that supports tissue repair before degrading away.

Locate has additional complementary technologies in cell therapy bioprocessing (RPMax; Reversible Porous Matrix for trypsin-free 3D cell culture) and intracellular delivery (IntraStem high-performance carrier peptide).


For further information please email or call +44 (0)115 784 0041..

Follw us on LinkedIn

For more up-to-date news regarding Locate Therapeutics, please visit our Linked-In page.

Recent news

Locate Therapeutics closes £2 million investment round investment to fast track development of innovative cell therapy programs
Underwritten by Mercia Fund Managers, this cash injection will help the firm to fast-track its innovative TAOS™ matrix system
Read more >

Locate Therapeutics Achieves ISO 13845 Certification
Locate Therapeutics has successfully achieved EN ISO 13845:2016 certification for the design, development, and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration.
Read more >

Recent Paper

Dixon, J.E., Osman, G., Morris, G.E., Markides, H., Rotherham, M., Bayoussef, Z., El Haj, A.J., Denning, C. and Shakesheff, K.M., 2016. Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides. Proceedings of the National Academy of Sciences, 113(3), pp.E291-E299.

More news >

© 2014 Locate Therapeutics Limited.

All rights reserved.

Registered in England number 04202562.

Locate Therapeutics Limited


Thane Road


Nottingham NG90 6BH

United Kingdom


+44 (0)115 784 0041

hogan outlet nike air max pas cher louboutin pas cher air jordan pas cher nike air max pas cher air jordan pas cher louboutin pas cher nike air max pas cher louboutin pas cher nike air max pas cher fitflop sandaler udsalg nike air max pas cher fitflop sandaler udsalg nike air max pas cher fitflop sandaler udsalg fitflop sandaler udsalg fitflop sandaler udsalg